collection
MENU ▼
Read by QxMD icon Read
search

Coronary Care Unit

shared collection
72 papers 25 to 100 followers
https://read.qxmd.com/read/31095902/impella-cp-use-in-patients-with-non-ischaemic-cardiogenic-shock
#1
Octavian Maniuc, Tim Salinger, Fabian Anders, Jonas Müntze, Dan Liu, Kai Hu, Georg Ertl, Stefan Frantz, Peter Nordbeck
AIMS: From the various mechanical cardiac assist devices and indications available, the use of the percutaneous intraventricular Impella CP pump is usually restricted to acute ischaemic shock or prophylactic indications in high-risk interventions. In the present study, we investigated clinical usefulness of the Impella CP device in patients with non-ischaemic cardiogenic shock as compared with acute ischaemia. METHODS AND RESULTS: In this retrospective single-centre analysis, patients who received an Impella CP at the University Hospital Würzburg between 2013 and 2017 due to non-ischaemic cardiogenic shock were age-matched 2:1 with patients receiving the device due to ischaemic cardiogenic shock...
May 16, 2019: ESC Heart Failure
https://read.qxmd.com/read/31100708/major-publications-in-critical-care-pharmacotherapy-literature-in-2018
#2
REVIEW
Andrea Sikora Newsome, Brittany D Bissell, Lisa D Burry, Aubrey A Defayette, David J Gagnon, Brian W Gilbert, C Joseph Kramer, Christopher J Miller, Michael Semanco, Melanie N Smith, Drayton A Hammond
PURPOSE: To summarize selected original critical care pharmacotherapy research published in 2018. MATERIALS AND METHODS: The Critical Care Pharmacotherapy Literature Update (CCPLU) Group screened 32 journals monthly for impactful articles and reviewed 100 articles during 2018. Grading of Recommendations, Assessment, Development and Evaluations (GRADE) criteria were applied to all relevant articles included in the monthly CCPLU. Articles with a 1A grade, including one clinical practice guideline, two meta-analyses, and ten original research trials, were selected for review...
May 1, 2019: Journal of Critical Care
https://read.qxmd.com/read/31060863/dysrhythmias-and-heart-failure-complicating-acute-myocardial-infarction-an-emergency-medicine-review
#3
REVIEW
William T Davis, Tim Montrief, Alex Koyfman, Brit Long
INTRODUCTION: Patients with acute myocardial infarction (AMI) may suffer several complications after the acute event, including dysrhythmias and heart failure (HF). These complications place patients at risk for morbidity and mortality. OBJECTIVE: This narrative review evaluates literature and guideline recommendations relevant to the acute emergency department (ED) management of AMI complicated by dysrhythmia or HF, with a focus on evidence-based considerations for ED interventions...
April 27, 2019: American Journal of Emergency Medicine
https://read.qxmd.com/read/31022088/measuring-cardiac-output-at-the-bedside
#4
Stephen J Huang
PURPOSE OF REVIEW: Bedside cardiac output (CO) measurement is an important part of routine hemodynamic monitoring in the differential diagnosis of circulatory shock and fluid management. Different choices of CO measurement devices are available. The purpose of this review is to review the importance of CO [or stroke volume (SV)] measurement and to discuss the various methods (devices) used in determination of CO. RECENT FINDINGS: CO measurement devices can be classified into two types: those use simple physical principles with minimal assumptions, and those predicting CO via mathematical modelling with a number of assumptions...
June 2019: Current Opinion in Critical Care
https://read.qxmd.com/read/30947926/cardiac-critical-care-training-pathways-and-transition-to-early-career
#5
EDITORIAL
P Elliott Miller, Benjamin B Kenigsberg, Brandon M Wiley
No abstract text is available yet for this article.
April 9, 2019: Journal of the American College of Cardiology
https://read.qxmd.com/read/30883387/editorial-haemodynamic-monitoring-the-why-when-which-and-what
#6
Anthony S McLean
No abstract text is available yet for this article.
June 2019: Current Opinion in Critical Care
https://read.qxmd.com/read/30943783/device-therapy-and-arrhythmia-management-in-left-ventricular-assist-device-recipients-a-scientific-statement-from-the-american-heart-association
#7
Rakesh Gopinathannair, William K Cornwell, Jonathan W Dukes, Christopher R Ellis, Kathleen T Hickey, José A Joglar, Francis D Pagani, Henri Roukoz, Mark S Slaughter, Kristen K Patton
Left ventricular assist devices (LVADs) are an increasingly used strategy for the management of patients with advanced heart failure with reduced ejection fraction. Although these devices effectively improve survival, atrial and ventricular arrhythmias are common, predispose these patients to additional risk, and complicate patient management. However, there is no consensus on best practices for the medical management of these arrhythmias or on the optimal timing for procedural interventions in patients with refractory arrhythmias...
April 4, 2019: Circulation
https://read.qxmd.com/read/30839374/update-in-electrical-storm-therapy
#8
Dragos Cozma, Diana Tint, Nandor Szegedi, Zoltan Sallo, Laszlo Geller
BACKGROUND: Electrical storm (ES) is a major life-threatening event, which announces a possible negative outcome and poor prognosis and poses challenging questions concerning etiology and management. DATA SOURCES: A literature search was conducted through MEDLINE and EMBASE (past 30 years until the end of September 2018) using the following search terms: ES, ventricular fibrillation, ventricular tachycardia, ablation, and implantable defibrillator. Clinicaltrials...
March 2019: American Journal of Therapeutics
https://read.qxmd.com/read/30724815/high-central-venous-to-arterial-co2-difference-is-associated-with-poor-outcomes-in-patients-after-cardiac-surgery-a-propensity-score-analysis
#9
Tao Chen, Tuo Pan, Xuan Luo, Dongjin Wang
PURPOSE: In contrast to arterial lactate, previous studies have proposed central venous-to-arterial CO2 difference (P (v-a)CO2) as a more useful guide for categorizing patients at risk of developing septic shock. It is worthwhile studying P (v-a)CO2 in determining whether it could serve as a useful predictor for poor postoperative outcomes in patients undergoing cardiac surgery. We investigated the ability of P(v-a)CO2 to predict poor outcomes of patients with postoperative cardiogenic shock...
February 1, 2019: Shock
https://read.qxmd.com/read/30608880/hospital-variation-in-the-utilization-of-short-term-nondurable-mechanical-circulatory-support-in-myocardial-infarction-complicated-by-cardiogenic-shock
#10
Jordan B Strom, Yuansong Zhao, Changyu Shen, Mabel Chung, Duane S Pinto, Jeffrey J Popma, David J Cohen, Robert W Yeh
BACKGROUND: Limited knowledge exists on inter-hospital variation in the utilization of short-term, nondurable mechanical circulatory support (MCS) for myocardial infarction (MI) complicated by cardiogenic shock (CS). METHODS AND RESULTS: Hospitalizations for MI with CS in 2014 in a nationally representative all-payer database were included. The proportion of hospitalizations for MI with CS using MCS (MCS ratio) and in-hospital mortality were evaluated. Hospital characteristics and outcomes were compared across quartiles of MCS usage...
January 2019: Circulation. Cardiovascular Interventions
https://read.qxmd.com/read/30572756/passive-leg-raise-feasibility-and-safety-of-the-maneuver-in-patients-with-undifferentiated-shock
#11
William Toppen, Elizabeth Aquije Montoya, Stephanie Ong, Daniela Markovic, Yuhan Kao, Xueqing Xu, Alan Chiem, Maxime Cannesson, David Berlin, Igor Barjaktarevic
PURPOSE: Passive leg raise (PLR), in combination with technologies capable of capturing stroke volume changes, has been widely adopted in the management of shock. However, dedicated evaluation of safety, feasibility, and receptiveness of patients and nursing staff to PLR maneuver is missing. METHODS: A noninterventional, prospective trial recruited adult patients with onset of undifferentiated shock within 24 hours with persistent vasopressor requirements despite fluid resuscitation...
December 20, 2018: Journal of Intensive Care Medicine
https://read.qxmd.com/read/29554243/predicting-the-development-of-in-hospital-cardiogenic-shock-in-patients-with-st-segment-elevation-myocardial-infarction-treated-by-primary-percutaneous-coronary-intervention-the-orbi-risk-score
#12
Vincent Auffret, Yves Cottin, Guillaume Leurent, Martine Gilard, Jean-Claude Beer, Amer Zabalawi, Frédéric Chagué, Emanuelle Filippi, Damien Brunet, Jean-Philippe Hacot, Philippe Brunel, Mourad Mejri, Luc Lorgis, Gilles Rouault, Philippes Druelles, Jean-Christophe Cornily, Romain Didier, Emilie Bot, Bertrand Boulanger, Isabelle Coudert, Aurélie Loirat, Marc Bedossa, Dominique Boulmier, Maud Maza, Marielle Le Guellec, Rishi Puri, Marianne Zeller, Hervé Le Breton
Aims: To derive and validate a readily useable risk score to identify patients at high-risk of in-hospital ST-segment elevation myocardial infarction (STEMI)-related cardiogenic shock (CS). Methods and results: In all, 6838 patients without CS on admission and treated by primary percutaneous coronary intervention (pPCI), included in the Observatoire Régional Breton sur l'Infarctus (ORBI), served as a derivation cohort, and 2208 patients included in the obseRvatoire des Infarctus de Côte-d'Or (RICO) constituted the external validation cohort...
June 7, 2018: European Heart Journal
https://read.qxmd.com/read/30305136/the-meaning-of-blood-pressure
#13
REVIEW
S Magder
Measurement of arterial pressure is one of the most basic elements of patient management. Arterial pressure is determined by the volume ejected by the heart into the arteries, the elastance of the walls of the arteries, and the rate at which the blood flows out of the arteries. This review will discuss the three forces that determine the pressure in a vessel: elastic, kinetic, and gravitational energy. Emphasis will be placed on the importance of the distribution of arterial resistances, the elastance of the walls of the large vessels, and critical closing pressures in small arteries and arterioles...
October 11, 2018: Critical Care: the Official Journal of the Critical Care Forum
https://read.qxmd.com/read/30540968/crystalloids-vs-colloids-for-fluid-resuscitation-in-the-intensive-care-unit-a-systematic-review-and-meta-analysis
#14
REVIEW
Greg S Martin, Paul Bassett
PURPOSE: Guidelines recommend crystalloids for fluid resuscitation in sepsis/shock and switching to albumin in cases where crystalloids are insufficient. We evaluated hemodynamic response to crystalloids/colloids in critically ill adults. MATERIALS AND METHODS: The primary research question was: "Are crystalloids sufficient for volume replacement in severe indications (intensive care unit [ICU]/critical illness)?" Randomized, controlled trials (RCTs) were identified using PubMed and EMBASE, and screened against predefined inclusion/exclusion criteria...
April 2019: Journal of Critical Care
https://read.qxmd.com/read/30409433/2018-international-consensus-on-cardiopulmonary-resuscitation-and-emergency-cardiovascular-care-science-with-treatment-recommendations-summary
#15
Jasmeet Soar, Michael W Donnino, Ian Maconochie, Richard Aickin, Dianne L Atkins, Lars W Andersen, Katherine M Berg, Robert Bingham, Bernd W Böttiger, Clifton W Callaway, Keith Couper, Thomaz Bittencourt Couto, Allan R de Caen, Charles D Deakin, Ian R Drennan, Anne-Marie Guerguerian, Eric J Lavonas, Peter A Meaney, Vinay M Nadkarni, Robert W Neumar, Kee-Chong Ng, Tonia C Nicholson, Gabrielle A Nuthall, Shinichiro Ohshimo, Brian J O'Neil, Gene Yong-Kwang Ong, Edison F Paiva, Michael J Parr, Amelia G Reis, Joshua C Reynolds, Giuseppe Ristagno, Claudio Sandroni, Stephen M Schexnayder, Barnaby R Scholefield, Naoki Shimizu, Janice A Tijssen, Patrick Van de Voorde, Tzong-Luen Wang, Michelle Welsford, Mary Fran Hazinski, Jerry P Nolan, Peter T Morley
The International Liaison Committee on Resuscitation has initiated a continuous review of new, peer-reviewed, published cardiopulmonary resuscitation science. This is the second annual summary of International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations that includes the most recent cardiopulmonary resuscitation science reviewed by the International Liaison Committee on Resuscitation. This summary addresses the role of antiarrhythmic drugs in adults and children and includes the Advanced Life Support Task Force and Pediatric Task Force consensus statements, which summarize the most recent published evidence and an assessment of the quality of the evidence based on Grading of Recommendations, Assessment, Development, and Evaluation criteria...
December 2018: Resuscitation
https://read.qxmd.com/read/30467028/color-doppler-artifact-masking-iatrogenic-aortic-valve-injury-related-to-an-impella-device
#16
Edward Hong, Tariq Naseem
The Impella (Abiomed, Danvers, MA) is a minimally invasive transvalvular left ventricular assist device (LVAD) that effectively unloads the left ventricle (LV), especially in patients with ventricular arrhythmias in the setting of a venous-arterial extracorporeal membrane oxygenator (VA ECMO).1,2 Utilization of the Impella device has increased significantly in the last few years for high-risk percutaneous coronary intervention and cardiogenic shock because of its relatively easy implantation in the catheterization lab and the operating room...
September 27, 2018: Journal of Cardiothoracic and Vascular Anesthesia
https://read.qxmd.com/read/30456984/long-term-survival-after-early-unloading-with-impella-cp-%C3%A2-in-acute-myocardial-infarction-complicated-by-cardiogenic-shock
#17
Tobias Loehn, William W O'Neill, Bjoern Lange, Christian Pfluecke, Tina Schweigler, Johannes Mierke, Nadine Waessnig, Adrian Mahlmann, Akram Youssef, Uwe Speiser, Ruth H Strasser, Karim Ibrahim
BACKGROUND: The use of percutaneous left ventricular assist devices in patients with acute myocardial infarction complicated by cardiogenic shock (AMICS) is evolving. The aim of the study was to assess the long-term outcome of patients with AMICS depending on early initiation of Impella CP® support prior to a percutaneous coronary intervention (PCI). METHODS: We retrospectively reviewed all patients who underwent PCI and Impella CP® support between 2014 and 2016 for AMICS at our institution...
November 20, 2018: European Heart Journal. Acute Cardiovascular Care
https://read.qxmd.com/read/30460719/the-role-of-different-mechanical-circulatory-support-devices-and-their-timing-of-implantation-on-myocardial-damage-and-mid-term-recovery-in-acute-myocardial-infarction-related-cardiogenic-shock
#18
Marina Pieri, Tania Sorrentino, Michele Oppizzi, Giulio Melisurgo, Rosalba Lembo, Antonio Colombo, Alberto Zangrillo, Federico Pappalardo
OBJECTIVES: Aim of the study was to assess in-hospital survival rate and the degree of myocardial recovery after MCS treatment (IABP or IMPELLA) at discharge and at 6 months in patients with AMI-CS and planned early percutaneous revascularization. BACKGROUND: All studies on MCS for acute myocardial infarction related cardiogenic shock (AMI-CS) focused on its impact on in-hospital mortality; however, few data about its role on myocardial recovery are available. METHODS: Retrospective study on 64 patients: 36 patients (56%) received IABP and 28 (44%) Impella 2...
December 2018: Journal of Interventional Cardiology
https://read.qxmd.com/read/30286922/combining-oral-anticoagulants-with-platelet-inhibitors-in-patients-with-atrial-fibrillation-and-coronary-disease
#19
Caroline Sindet-Pedersen, Morten Lamberts, Laila Staerk, Anders Nissen Bonde, Jeffrey S Berger, Jannik Langtved Pallisgaard, Morten Lock Hansen, Christian Torp-Pedersen, Gunnar H Gislason, Jonas Bjerring Olesen
BACKGROUND: The optimal treatment strategy when combining antiplatelets with oral anticoagulants in patients with atrial fibrillation (AF) and myocardial infarction (MI) or undergoing percutaneous coronary intervention (PCI) is unknown. OBJECTIVES: The authors investigated the risk of bleeding, ischemic stroke, MI, and all-cause mortality associated with direct oral anticoagulants (DOACs) compared with vitamin K antagonists (VKAs) in combination with aspirin, clopidogrel, or both in patients with AF following MI and/or PCI...
October 9, 2018: Journal of the American College of Cardiology
https://read.qxmd.com/read/30266628/continuous-renal-replacement-therapy-who-when-why-and-how
#20
REVIEW
Srijan Tandukar, Paul M Palevsky
Continuous renal replacement therapy (CRRT) is commonly used to provide renal support for critically ill patients with acute kidney injury, particularly patients who are hemodynamically unstable. A variety of techniques that differ in their mode of solute clearance may be used, including continuous venovenous hemofiltration with predominantly convective solute clearance, continuous venovenous hemodialysis with predominantly diffusive solute clearance, and continuous venovenous hemodiafiltration, which combines both dialysis and hemofiltration...
September 25, 2018: Chest
label_collection
label_collection
3855
1
2
2018-10-10 16:26:35
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"